| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ceranib-2 | CTRPv2 | pan-cancer | AAC | 0.004 | 0.9 |
| mRNA | QS11 | GDSC1000 | pan-cancer | AAC | 0.0043 | 0.9 |
| mRNA | istradefylline | CTRPv2 | pan-cancer | AAC | -0.0065 | 0.9 |
| mRNA | Nilotinib | CTRPv2 | pan-cancer | AAC | 0.0043 | 0.9 |
| mRNA | Bexarotene | GDSC1000 | pan-cancer | AAC | 0.0042 | 0.9 |
| mRNA | AR-42 | GDSC1000 | pan-cancer | AAC | 0.0035 | 0.9 |
| mRNA | AICAR | GDSC1000 | pan-cancer | AAC | 0.0037 | 0.9 |
| mRNA | Erlotinib | UHNBreast | pan-cancer | AAC | 0.033 | 0.9 |
| mRNA | WZ-1-84 | GDSC1000 | pan-cancer | AAC | 0.0058 | 0.9 |
| mRNA | CCT018159 | GDSC1000 | pan-cancer | AAC | 0.0038 | 0.9 |